Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CTIC up on Xyotax news

Cell Therapeutics (CTIC) was up $1.73 (13%) to $14.75

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE